Global Decentralized Clinical Trials (DCTs) Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Report ID: GIR2101290003 | Category: Medical Care | Pages: 129 | Format: PDF | Published Date: July 01,2021

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Decentralized Clinical Trials (DCTs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Decentralized Clinical Trials (DCTs) size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Decentralized Clinical Trials (DCTs) market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Decentralized Clinical Trials (DCTs) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Interventional Trials
    Observational Trials
    Expanded Access Trials

Market segment by Application, can be divided into
    Oncology
    Cardiovascular Disease
    Others

Market segment by players, this report covers
    ICON Plc
    LEO Innovation Lab
    Science 37
    PRA Health Sciences
    Clinical Ink
    Parexel
    Medable
    Oracle
    CRF Health
    Medidata
    Covance
    IQVIA
    PPD
    PWNHealth, LLC
    Medrio

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

1 Market Overview
    1.1 Product Overview and Scope of Decentralized Clinical Trials (DCTs)
    1.2 Classification of Decentralized Clinical Trials (DCTs) by Type
        1.2.1 Overview: Global Decentralized Clinical Trials (DCTs) Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Type in 2020
        1.2.3 Interventional Trials
        1.2.4 Observational Trials
        1.2.5 Expanded Access Trials
    1.3 Global Decentralized Clinical Trials (DCTs) Market by Application
        1.3.1 Overview: Global Decentralized Clinical Trials (DCTs) Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Oncology
        1.3.3 Cardiovascular Disease
        1.3.4 Others
    1.4 Global Decentralized Clinical Trials (DCTs) Market Size & Forecast
    1.5 Global Decentralized Clinical Trials (DCTs) Market Size and Forecast by Region
        1.5.1 Global Decentralized Clinical Trials (DCTs) Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Decentralized Clinical Trials (DCTs) Market Size by Region, (2016-2021)
        1.5.3 North America Decentralized Clinical Trials (DCTs) Market Size and Prospect (2016-2026)
        1.5.4 Europe Decentralized Clinical Trials (DCTs) Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size and Prospect (2016-2026)
        1.5.6 South America Decentralized Clinical Trials (DCTs) Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Decentralized Clinical Trials (DCTs) Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Decentralized Clinical Trials (DCTs) Market Drivers
        1.6.2 Decentralized Clinical Trials (DCTs) Market Restraints
        1.6.3 Decentralized Clinical Trials (DCTs) Trends Analysis
2 Company Profiles
    2.1 ICON Plc
        2.1.1 ICON Plc Details
        2.1.2 ICON Plc Major Business
        2.1.3 ICON Plc Decentralized Clinical Trials (DCTs) Product and Solutions
        2.1.4 ICON Plc Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 ICON Plc Recent Developments and Future Plans
    2.2 LEO Innovation Lab
        2.2.1 LEO Innovation Lab Details
        2.2.2 LEO Innovation Lab Major Business
        2.2.3 LEO Innovation Lab Decentralized Clinical Trials (DCTs) Product and Solutions
        2.2.4 LEO Innovation Lab Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 LEO Innovation Lab Recent Developments and Future Plans
    2.3 Science 37
        2.3.1 Science 37 Details
        2.3.2 Science 37 Major Business
        2.3.3 Science 37 Decentralized Clinical Trials (DCTs) Product and Solutions
        2.3.4 Science 37 Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Science 37 Recent Developments and Future Plans
    2.4 PRA Health Sciences
        2.4.1 PRA Health Sciences Details
        2.4.2 PRA Health Sciences Major Business
        2.4.3 PRA Health Sciences Decentralized Clinical Trials (DCTs) Product and Solutions
        2.4.4 PRA Health Sciences Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 PRA Health Sciences Recent Developments and Future Plans
    2.5 Clinical Ink
        2.5.1 Clinical Ink Details
        2.5.2 Clinical Ink Major Business
        2.5.3 Clinical Ink Decentralized Clinical Trials (DCTs) Product and Solutions
        2.5.4 Clinical Ink Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Clinical Ink Recent Developments and Future Plans
    2.6 Parexel
        2.6.1 Parexel Details
        2.6.2 Parexel Major Business
        2.6.3 Parexel Decentralized Clinical Trials (DCTs) Product and Solutions
        2.6.4 Parexel Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Parexel Recent Developments and Future Plans
    2.7 Medable
        2.7.1 Medable Details
        2.7.2 Medable Major Business
        2.7.3 Medable Decentralized Clinical Trials (DCTs) Product and Solutions
        2.7.4 Medable Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Medable Recent Developments and Future Plans
    2.8 Oracle
        2.8.1 Oracle Details
        2.8.2 Oracle Major Business
        2.8.3 Oracle Decentralized Clinical Trials (DCTs) Product and Solutions
        2.8.4 Oracle Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Oracle Recent Developments and Future Plans
    2.9 CRF Health
        2.9.1 CRF Health Details
        2.9.2 CRF Health Major Business
        2.9.3 CRF Health Decentralized Clinical Trials (DCTs) Product and Solutions
        2.9.4 CRF Health Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 CRF Health Recent Developments and Future Plans
    2.10 Medidata 
        2.10.1 Medidata Details
        2.10.2 Medidata Major Business
        2.10.3 Medidata Decentralized Clinical Trials (DCTs) Product and Solutions
        2.10.4 Medidata Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Medidata Recent Developments and Future Plans
    2.11 Covance
        2.11.1 Covance Details
        2.11.2 Covance Major Business
        2.11.3 Covance Decentralized Clinical Trials (DCTs) Product and Solutions
        2.11.4 Covance Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Covance Recent Developments and Future Plans
    2.12 IQVIA
        2.12.1 IQVIA Details
        2.12.2 IQVIA Major Business
        2.12.3 IQVIA Decentralized Clinical Trials (DCTs) Product and Solutions
        2.12.4 IQVIA Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 IQVIA Recent Developments and Future Plans
    2.13 PPD
        2.13.1 PPD Details
        2.13.2 PPD Major Business
        2.13.3 PPD Decentralized Clinical Trials (DCTs) Product and Solutions
        2.13.4 PPD Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 PPD Recent Developments and Future Plans
    2.14 PWNHealth, LLC
        2.14.1 PWNHealth, LLC Details
        2.14.2 PWNHealth, LLC Major Business
        2.14.3 PWNHealth, LLC Decentralized Clinical Trials (DCTs) Product and Solutions
        2.14.4 PWNHealth, LLC Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 PWNHealth, LLC Recent Developments and Future Plans
    2.15 Medrio
        2.15.1 Medrio Details
        2.15.2 Medrio Major Business
        2.15.3 Medrio Decentralized Clinical Trials (DCTs) Product and Solutions
        2.15.4 Medrio Decentralized Clinical Trials (DCTs) Revenue, Gross Margin and Market Share (2019-2021)
        2.15.5 Medrio Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Decentralized Clinical Trials (DCTs) Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Decentralized Clinical Trials (DCTs) Players Market Share
        3.2.2 Top 10 Decentralized Clinical Trials (DCTs) Players Market Share
        3.2.3 Market Competition Trend
    3.3 Decentralized Clinical Trials (DCTs) Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Decentralized Clinical Trials (DCTs) Revenue and Market Share by Type (2016-2021)
    4.2 Global Decentralized Clinical Trials (DCTs) Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Application (2016-2021)
    5.2 Decentralized Clinical Trials (DCTs) Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America Decentralized Clinical Trials (DCTs) Revenue by Type (2016-2026)
    6.2 North America Decentralized Clinical Trials (DCTs) Revenue by Application (2016-2026)
    6.3 North America Decentralized Clinical Trials (DCTs) Market Size by Country
        6.3.1 North America Decentralized Clinical Trials (DCTs) Revenue by Country (2016-2026)
        6.3.2 United States Decentralized Clinical Trials (DCTs) Market Size and Forecast (2016-2026)
        6.3.3 Canada Decentralized Clinical Trials (DCTs) Market Size and Forecast (2016-2026)
        6.3.4 Mexico Decentralized Clinical Trials (DCTs) Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
    7.1 Europe Decentralized Clinical Trials (DCTs) Revenue by Type (2016-2026)
    7.2 Europe Decentralized Clinical Trials (DCTs) Revenue by Application (2016-2026)
    7.3 Europe Decentralized Clinical Trials (DCTs) Market Size by Country
        7.3.1 Europe Decentralized Clinical Trials (DCTs) Revenue by Country (2016-2026)
        7.3.2 Germany Decentralized Clinical Trials (DCTs) Market Size and Forecast (2016-2026)
        7.3.3 France Decentralized Clinical Trials (DCTs) Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Decentralized Clinical Trials (DCTs) Market Size and Forecast (2016-2026)
        7.3.5 Russia Decentralized Clinical Trials (DCTs) Market Size and Forecast (2016-2026)
        7.3.6 Italy Decentralized Clinical Trials (DCTs) Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Decentralized Clinical Trials (DCTs) Revenue by Type (2016-2026)
    8.2 Asia-Pacific Decentralized Clinical Trials (DCTs) Revenue by Application (2016-2026)
    8.3 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Region
        8.3.1 Asia-Pacific Decentralized Clinical Trials (DCTs) Revenue by Region (2016-2026)
        8.3.2 China Decentralized Clinical Trials (DCTs) Market Size and Forecast (2016-2026)
        8.3.3 Japan Decentralized Clinical Trials (DCTs) Market Size and Forecast (2016-2026)
        8.3.4 South Korea Decentralized Clinical Trials (DCTs) Market Size and Forecast (2016-2026)
        8.3.5 India Decentralized Clinical Trials (DCTs) Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Decentralized Clinical Trials (DCTs) Market Size and Forecast (2016-2026)
        8.3.7 Australia Decentralized Clinical Trials (DCTs) Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
    9.1 South America Decentralized Clinical Trials (DCTs) Revenue by Type (2016-2026)
    9.2 South America Decentralized Clinical Trials (DCTs) Revenue by Application (2016-2026)
    9.3 South America Decentralized Clinical Trials (DCTs) Market Size by Country
        9.3.1 South America Decentralized Clinical Trials (DCTs) Revenue by Country (2016-2026)
        9.3.2 Brazil Decentralized Clinical Trials (DCTs) Market Size and Forecast (2016-2026)
        9.3.3 Argentina Decentralized Clinical Trials (DCTs) Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Decentralized Clinical Trials (DCTs) Revenue by Type (2016-2026)
    10.2 Middle East & Africa Decentralized Clinical Trials (DCTs) Revenue by Application (2016-2026)
    10.3 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country
        10.3.1 Middle East & Africa Decentralized Clinical Trials (DCTs) Revenue by Country (2016-2026)
        10.3.2 Turkey Decentralized Clinical Trials (DCTs) Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Decentralized Clinical Trials (DCTs) Market Size and Forecast (2016-2026)
        10.3.4 UAE Decentralized Clinical Trials (DCTs) Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Decentralized Clinical Trials (DCTs) Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?